Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Montefiore Medical Center-Weiler Division, The Bronx

Temple Lung Center Pulmonary & Critical Care Medicine, Philadelphia

Pulmonary Associates of Richmond Inc, Richmond

American Health Research, Charlotte

Neem Research Group Inc, Columbia

Spartanburg Medical Research, Spartanburg

Gaffney Pharmaceutical Research, Gaffney

Lowcountry Lung and Critical Care, Charleston

Greenville Pharmaceutical Research, Greenville

Clinical Research of Rock Hill, Rock Hill

Medical Associates of North Georgia, Canton

River Birch Research Alliance LLC, Blue Ridge

East Coast Institute for Research, Jacksonville

Florida Premier Research Institute, Winter Park

Central Florida Pulmonary Group, P.A., Orlando

San Marcus Research Clinic Inc., Miami

St. Paul Medical Research Center Inc., Miami

IMIC, Inc., Miami

Elite Clinical Research, Miami

South Florida Research Phase I-IV, Miami

Health & Life Research Solutions Inc., Miami

Gary J. Richmond, MD, PA, Fort Lauderdale

Concept Clinical Trials, LLC, Tamarac

Axcess Medical Research, Wellington

Research Alliance, St. Petersburg

Bay Area Chest Physicians, Clearwater

Bassette Medical Research Inc., Sebring

Advanced Research Institute, Inc., New Port Richey

Pulmonary Disease Specialists PA, Kissimmee

Jasper Summit Research LLC, Jasper

Kentucky Research Group, Louisville

Graves-Gilbert Clinic, Bowling Green

University Hospitals Case Medical Center, Cleveland

Physician HealthCare Network, PC, Port Huron

Veritas Clinical Specialties, Ltd, Topeka

MedPharmics LLC, Metairie

Pioneer Research Solutions, Inc., Sugar Land

Pulmonary Associates P.A., Phoenix

Clinical Trial Connection, Flagstaff

Radin Cardiovascular Medical Associates, Newport Beach

Zain Research LLC, Richland

Western Connecticut Medical Group PC, Danbury

Waterbury Pulmonary Associates, Waterbury